Literature DB >> 31918744

Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Serena Colafrancesco1, Maria Manara2, Alessandra Bortoluzzi3, Teodora Serban4, Gerolamo Bianchi4, Luca Cantarini5, Francesco Ciccia6, Lorenzo Dagna7, Marcello Govoni3, Carlomaurizio Montecucco8, Roberta Priori9, Angelo Ravelli10, Paolo Sfriso11, Luigi Sinigaglia2.   

Abstract

Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.

Entities:  

Year:  2020        PMID： 31918744      PMCID： PMC6953133          DOI： 10.1186/s13075-019-2094-5

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN： 1478-6354            Impact factor:   5.156


Correction to: Arthritis Res Ther (2019) 21:275 https://doi.org/10.1186/s13075-019-2021-9 Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.
  1 in total

1.  Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Authors:  Serena Colafrancesco; Maria Manara; Alessandra Bortoluzzi; Teodora Serban; Gerolamo Bianchi; Luca Cantarini; Francesco Ciccia; Lorenzo Dagna; Marcello Govoni; Carlomaurizio Montecucco; Roberta Priori; Angelo Ravelli; Paolo Sfriso; Luigi Sinigaglia
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.